MétaCan
Menu
Back to cohort
Record W2767868848 · doi:10.1093/neuonc/nox168.978

SURG-22. QUALITY BASED ASSESSMENT OF THE COST-EFFECTIVENESS OF 5-ALA IN HIGH GRADE GLIOMA SURGERY: A SYSTEMATIC REVIEW

2017· review· en· W2767868848 on OpenAlexaff
Rahel T Zewude, Laureen D. Hachem, Alireza Mansouri

Bibliographic record

VenueNeuro-Oncology · 2017
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsMedicineGliomaMEDLINECost effectivenessSystematic reviewQuality-adjusted life yearQuality of life (healthcare)SurgeryEvidence-based medicineCost–benefit analysisPathologyAlternative medicine

Abstract

fetched live from OpenAlex

High grade gliomas (HGG) are the most common primary malignant brain tumors in adults. While the infiltrative nature of HGG makes safe maximal resections challenging, studies on the use of adjuncts such as 5-ALA have shown much promise. The accumulating clinical evidence has led to approval of 5-ALA for clinical practice in Europe but not in North America. Prior to integration into routine practice, data on the health economic impact of novel agents are considered by regulatory health agencies. With respect to 5-ALA, this evidence is limited and requires further investigation. A systematic review and synthesis of the state of evidence on health economic assessment of 5-ALA in HGG surgery was conducted. Medline, EMBASE, CRD, EconPapers and Cochrane databases were searched for keywords related to glioma, cost-effectiveness and 5-ALA. Three primary studies were identified (1 Portuguese, 1 Spanish and 1 French). One measured incremental cost-effectiveness ratio (ICER) of 5-ALA per gained Quality Adjusted Life Year (QALY) compared to white light surgery. Another assessed cost-effectiveness based on incremental cost per QALY and per complete resection. The first study reported ICER of €9100/ QALY while the second reported €9021/QALY. Both studies reported that 5-ALA was well below their respective national cost-effectiveness thresholds. The third study compared glioblastoma (GBM) surgical costs during a period before 5-ALA’s introduction and after it started being widely used. The difference in average costs of GBM surgery during these periods, €9353 compared to €10,118, was not significant. None of these studies considered patient’s perspective and indirect costs in their analysis. While clinical evidence in favor of 5-ALA as intraoperative adjunct is accumulating, health economic data is limited and of low quality. Prospective high quality evaluations on cost-effectiveness of 5-ALA are necessary prior to its regulatory approval and routine clinical use in North America.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.016
metaresearch head score (Gemma)0.075
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.016
Threshold uncertainty score0.085

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0160.075
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0140.022
Bibliometrics0.0150.014
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0110.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.613
GPT teacher head0.559
Teacher spread0.054 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207